VENKYS (INDIA)
Back to Income Statement
|
VENKYS (INDIA) Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹4,234 Cr | ₹4,400 Cr | ₹3,117 Cr | ₹3,261 Cr | ₹3,043 Cr |
What is the latest Revenue of VENKYS (INDIA) ?
Year | Revenue |
---|---|
Mar2024 | ₹4,234 Cr |
Mar2023 | ₹4,400 Cr |
Mar2022 | ₹3,117 Cr |
Mar2021 | ₹3,261 Cr |
Mar2020 | ₹3,043 Cr |
How is Revenue of VENKYS (INDIA) Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹4,234 Cr | -3.79 | |
Mar2023 | ₹4,400 Cr | 41.19 | |
Mar2022 | ₹3,117 Cr | -4.43 | |
Mar2021 | ₹3,261 Cr | 7.16 | |
Mar2020 | ₹3,043 Cr | - |
Compare Revenue of peers of VENKYS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENKYS (INDIA) | ₹2,302.2 Cr | 1.1% | -0.1% | 1.6% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,333.2 Cr | 0% | 4.6% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,489.8 Cr | 15.2% | 43.4% | 108.6% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,298.6 Cr | 2.4% | -4.8% | -49.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹452.8 Cr | -9.3% | -12.6% | NA | Stock Analytics | |
INDO US BIOTECH | ₹322.8 Cr | -1% | -18.2% | -39.7% | Stock Analytics |
VENKYS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENKYS (INDIA) | 1.1% |
-0.1% |
1.6% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses